PMCPA Case Library

1,752 PMCPA Rulings.
Every One Analysed.

The only structured, searchable PMCPA case library in the UK. Expert video walkthroughs, podcast episodes, and MCQ assessments on every ruling — so you understand why companies breach the Code, not just that they did.

▶ Video analysis per case
🎧 Podcast per case
✍ MCQ + CPD certificate
🔒 From £299/year
1752+
Case Studies
5 min
Per Video
5 pts
Per Case Passed
8
Themes
📚
Subscribe for full case library access
Read free summaries below, or subscribe to unlock expert video walkthroughs, podcast audio and CPD certificates.
Sign in See plans ↓
Free — Browsing
✓ Browse all 1752+ case titles
✓ Filter by theme & therapy area
✓ See case reference, company & outcome
✗ Search by company or clause
✗ Video walkthroughs
✗ Podcast episodes
✗ MCQ assessments & CPD certificates
Subscribed — Full Access
✓ Search by company, clause & case ref
✓ Expert video walkthrough per case
✓ Podcast episode per case
✓ MCQ quiz — 5 CPD points per pass
✓ Personalised CPD completion certificate
✓ New cases added monthly
Subscribe from £299/year →
Search by company, clause, case reference... 🔒
All (1752) Social Media & Digital (720) HCP Hospitality & Meetings (431) Data & Publications (321) Off-label Promotion (219) Patient Organisations (44) Transfers of Value (9) Promotional Material (4) Samples & Gifts (2)
Therapy Area: All areas Other (360) Oncology (218) Cardiovascular (189) Respiratory (178) CNS & Neurology (169) Infectious Diseases (115) Diabetes (114) Rare Diseases (104) Immunology & Rheumatology (84) Dermatology (67) Obesity & Weight Management (63) Musculoskeletal & Bone (60) Ophthalmology (31)
Showing 31 results · Data & Publications · Respiratory  · Clear
🔒 Subscribers only
AUTH/3223/7/19
Data & Publications Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Boehringer Ingelheim
Boehringer Ingelheim Limited voluntarily admitted that the June 2019 issue of MIMS bore advertising for Spiolto Respimat (tiotropium and olodaterol) on more than two pages.The June 2019 MIMS contai…
Clauses: 9.1
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3087/9/18
Data & Publications Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
GlaxoSmithKline
The PMCPA Director opened a complaint (Paragraph 5.1) after a BMJ paper reported that GlaxoSmithKline (GSK) had 33 “due trials” without results on EUCTR (reported disclosure rate 88.7%). GSK …
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/2884/10/16
Data & Publications Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Intrapharm
A CCG medicines management team member complained about a letter Intrapharm sent to GP practices in the named CCG (ref ccf-222-001), copied to the PMCPA.The letter was headed “New Carbocisteine i…
Clauses: 9.1,9.2
2016 🔒 Subscribe
🔒 Subscribers only
AUTH/2701/2/14
Data & Publications Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
GlaxoSmithKline
An anonymous, contactable general practitioner complained about two bullet-point claims in two journal advertisements for Relvar Ellipta (fluticasone furoate/vilanterol) placed by GlaxoSmithKline U…
Clauses: NONE
2014 🔒 Subscribe
🔒 Subscribers only
AUTH/2588/3/13
Data & Publications Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Novartis breach
The Drug and Therapeutics Bulletin complained about a 16-page booklet, Evidence Review of Seebri Breezhaler (glycopyrronium bromide) (ref SBH12-CO17), issued by Novartis for use in formulary packs.…
Clauses: 9.1
2013 🔒 Subscribe
🔒 Subscribers only
AUTH/2649/10/13
Data & Publications Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
GSK joint working project
GlaxoSmithKline (GSK) made a voluntary admission that materials for an NHS joint working project were certified after the project had started.The joint working project ran from October 2011 to Octo…
Clauses: NONE
2013 🔒 Subscribe
🔒 Subscribers only
AUTH/2618/7/13
Data & Publications Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
AstraZeneca v Chiesi
AstraZeneca complained about a Chiesi promotional leavepiece for Fostair (formoterol/beclometasone pressurised inhalation solution), ref CHFOS20130051. The front-page headline stated: “New licenc…
Clauses: NONE
2013 🔒 Subscribe
🔒 Subscribers only
AUTH/2396/3/11
Data & Publications Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Chiesi
An anonymous GP complained about a “product standardization programme” in Northern Ireland involving Chiesi.The matter was noted as closely similar to an earlier case (AUTH/2352/8/10).The progr…
Clauses: NONE
2011 🔒 Subscribe
🔒 Subscribers only
AUTH/2401/4/11
Data & Publications Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Meda
An anonymous complainant raised a complaint about the promotion of Rhinolast by Meda.The PMCPA assessed the matter and concluded it was outwith the scope of the ABPI Code of Practice.
Clauses: NONE
2011 🔒 Subscribe
🔒 Subscribers only
AUTH/2406/5/11
Data & Publications Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Chiesi
A General Practitioner complained about the promotion of Fostair by Chiesi.The matter was assessed by the PMCPA as outwith the scope of the ABPI Code of Practice.No case report was issued because i…
Clauses: NONE
2011 🔒 Subscribe
🔒 Subscribers only
AUTH/2478/2/11
Data & Publications Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
GSK Seretide pricing and NHS “value” email
A pharmacist/clinical senior lecturer complained about a promotional email for Seretide (salmeterol/fluticasone) sent by GlaxoSmithKline UK Limited via eGuidelines.co.uk.The email headline stated S…
Clauses: NONE
2011 🔒 Subscribe
🔒 Subscribers only
AUTH/2352/8/10
Data & Publications Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Chiesi
GlaxoSmithKline (GSK) complained that Chiesi’s Clinical Support Service (CSS) in one NHS area facilitated a switch service rather than a genuine therapeutic review.GSK relied on: (1) a GP letter …
Clauses: 9.1,9.2
2010 🔒 Subscribe
🔒 Subscribers only
AUTH/2320/5/10
Data & Publications Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
AstraZeneca breached ABPI Code over unqualified inhaler lung-deposition comparisons (Symbicort Turbo
An anonymous, uncontactable complainant alleged an AstraZeneca representative gave incorrect information while promoting Symbicort Turbohaler (budesonide + formoterol) for asthma. The representativ…
Clauses: NONE
2010 🔒 Subscribe
🔒 Subscribers only
AUTH/2203/1/09
Data & Publications Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Pfizer
Johnson & Johnson Limited complained about a Champix (varenicline) journal advertisement (ref CHA432a) issued by Pfizer Limited and published in GP on 11 April 2008.The advertisement included t…
Clauses: 9.1,26.1
2009 🔒 Subscribe
🔒 Subscribers only
AUTH/2277/11/09
Data & Publications Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Flynn Pharma
A prescribing advisor to a teaching primary care trust (PCT) complained about an email advertisement sent to GPs by Flynn Pharma promoting Distaclor (cefaclor) for patients following influenza who …
Clauses: NONE
2009 🔒 Subscribe
🔒 Subscribers only
AUTH/2265/9/09
Data & Publications Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
AstraZeneca
A consultant respiratory physician complained about promotion of Symbicort (formoterol/budesonide) for COPD by a former AstraZeneca representative.A 20-page document titled “Effective Treatment o…
Clauses: NONE
2009 🔒 Subscribe
🔒 Subscribers only
AUTH/2106/3/08
Data & Publications Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Trinity-Chiesi Pharmaceuticals Ltd — Clenil (beclometasone)
An anonymous primary care trust (PCT) pharmacist complained about a letter (ref TRCLE20070433) from Trinity-Chiesi Pharmaceuticals Ltd promoting Clenil (beclometasone).The complainant alleged the l…
Clauses: 7.2,7.3,7.4
2008 🔒 Subscribe
🔒 Subscribers only
AUTH/2103/3/08
Data & Publications Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Trinity
An anonymous member of a primary care trust (PCT) medicines management team complained about a programme in a practice which allegedly advocated switching from beclometasone CFC and beclometasone C…
Clauses: NONE
2008 🔒 Subscribe
🔒 Subscribers only
AUTH/2097/2/08
Data & Publications Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Trinity
Teva UK Limited complained about Trinity-Chiesi Pharmaceuticals Ltd’s Clinic Support Service (CSS), focusing on two CSS pharmacist forms (ref TRCSS20040235) dated 2 and 24 October 2007.The forms,…
Clauses: NONE
2008 🔒 Subscribe
🔒 Subscribers only
AUTH/2148/7/08
Data & Publications Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Trinity
AstraZeneca UK Limited complained about a cost comparison chart used by Trinity-Chiesi Pharmaceuticals Ltd to promote Fostair (beclometasone 100mcg/formoterol 6mcg) for asthma.The chart compared Fo…
Clauses: NONE
2008 🔒 Subscribe
🔒 Subscribers only
AUTH/2178/10/08
Data & Publications Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Anonymous v GlaxoSmithKline
An anonymous, non-contactable complainant queried whether GlaxoSmithKline’s patient outcomes and information service (POINTS) complied with the ABPI Code.Concerns included: a complex authorisatio…
Clauses: NONE
2008 🔒 Subscribe
🔒 Subscribers only
AUTH/2096/1/08
Data & Publications Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Trinity-Chiesi breach
An anonymous complainant challenged a Prescriber (January 2008) journal advertisement for Fostair (beclometasone and formoterol) (ref TRFOS20070526).The allegation: the non-proprietary name was not…
Clauses: 4.3
2008 🔒 Subscribe
🔒 Subscribers only
AUTH/2017/7/07
Data & Publications Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
AUTH/2017/7/07 Anonymous v Teva
An anonymous Teva sales representative complained about pressure on reps to meet targets for Qvar by signing GP surgeries up to the “Enhanced Asthma Care Service” (EACS), delivered by an agency…
Clauses: NONE
2007 🔒 Subscribe
🔒 Subscribers only
AUTH/2007/5/07
Data & Publications Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Teva UK misleading superiority claim for Qvar leavepiece
Trinity-Chiesi complained about a Teva UK promotional leavepiece for Qvar (a CFC-free beclometasone dipropionate inhaler for asthma).The leavepiece (refs IV/QV/CNL/12/06A and IV/QV/CFC/01/07) carri…
Clauses: 9.1
2007 🔒 Subscribe
1 2 Next → Page 1 of 2 — 31 cases
Unlock the Full Case Library
Annual subscription — instant access, cancel anytime.
🏆
The only PMCPA case library of its kind
No other provider publishes a structured, searchable library of PMCPA rulings with video and podcast. A single half-day compliance workshop from a specialist provider typically costs £499+ — for one session. Individual access here is £299 for a full year of 2,000+ cases.
PMCPA Case Library — Team (100 seats)
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
Enquire for bulk pricing →
Individual
For a single learner
£299
per year
Less than a single half-day workshop
  • 1 user seat
  • All 1752+ case studies
  • Video + podcast per case
  • MCQ quiz per case
  • 5 points per case passed
  • New cases added monthly
Create account or sign in to buy
Most Popular
Team 5
Up to 5 team members
£999
per year (£200/seat)
£200/person — the most cost-effective team option
  • 5 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • New cases added monthly
  • Admin management portal
Create account or sign in to buy
Team 25+
25+ team members
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
  • 25 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • Bulk seat management
  • Priority support
Enquire for bulk pricing →

Questions? Email [email protected]  ·  14-day money-back guarantee  ·  Annual subscription, auto-renews